{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-22-002108","form_type":"8-K","ticker":"TMCI","cik":"0001630627","company_name":"TREACE MEDICAL CONCEPTS, INC.","filed_at":"2022-02-25T23:59:59+00:00","discovered_at":"2026-05-14T18:04:07.461307+00:00","generated_at":"2026-06-27T04:13:49.305103+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"John R. Treace to retire from board; Chairman James T. Treace reclassified as Class I director","bullets":["John R. Treace (father of CEO) will retire at the 2022 annual meeting and not stand for re-election.","Decision not related to any disagreement with the Company's operations, policies, or disclosures.","Board approved reclassification of Chairman James T. Treace to Class I director, effective upon John R. Treace's term expiration.","James T. Treace will stand for election as a Class I Director at the 2022 Annual Meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-22-002108","json":"https://secwatch.observer/filing/0000950170-22-002108.json","markdown":"https://secwatch.observer/filing/0000950170-22-002108.md","text":"https://secwatch.observer/filing/0000950170-22-002108.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1630627/000095017022002108/0000950170-22-002108-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1630627/000095017022002108/tmci-20220222.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T04:13:49.305103+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"409c6ca5c1","claim":"John R. Treace departed as director at TREACE MEDICAL CONCEPTS, INC..","evidence_excerpt":"On February 22, 2022, John R. Treace provided notice to the board of directors (the “ Board ”) of Treace Medical Concepts, Inc. (the “ Company ”) of his intent to retire from the Board at the expiration of his current term at the 2022 annual meeting of stockholders (the “ 2022 Annual Meeting ”) and not to stand for re-election.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1630627/000095017022002108/0000950170-22-002108-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"retire"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}